👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

India Stocks Fall as Troops Clash With China

Published 09/01/2020, 01:30 AM
Updated 09/01/2020, 01:36 AM
© Bloomberg. A digital ticker board is displayed at the Bombay Stock Exchange (BSE) building in Mumbai, India, on Monday, July 6, 2020. The Sensex is headed for a four-month high, even as India overtook Russia to become the country with the third-largest caseload of coronavirus infections. Only the U.S. and Brazil now have more infections than India. Photographer: Dhiraj Singh/Bloomberg
TGT
-
BSESN
-

(Bloomberg) -- Indian stocks reversed gains, halting a six-day advance, after the government said troops clashed with Chinese counterparts. The main stock index remained on course to cap its longest run of monthly gains since December.

A gauge of implied stock volatility surged after the announcement and the S&P BSE Sensex slipped 0.8% to 39,166.6 at 1:02 p.m. The measure’s 19% gain since June hasn’t been bettered since the six-month streak through August 2016 and the net $6.4 billion of India stocks bought by foreigners this month is set for the biggest monthly purchase in a decade. The NSE Nifty 50 Index fell 0.6%.

“Investors had put the geo-political tensions on the back burner, and it is now back into focus,” said Sameer Kalra, a strategist at Mumbai-based Target (NYSE:TGT) Investing. “Markets will be closely watching for signs of escalation.”

The latest military skirmish -- on Saturday -- follows a stand-off along the contested Himalayan border since May. Both India and China have moved thousands of troops, tanks, artillery guns and fighter jets close to the area.

The yield on India’s 10-year government bonds fell one basis points to 6%, while the rupee weakened 0.4% to 73.6675 per U.S. dollar.

Read: India and Chinese Troops Clash on Disputed Himalayan Border

The declines on the Sensex and Nifty were limited by gains in Reliance Industries Ltd., the nation’s most-valuable company. The stock climbed 0.8% and gave both gauges their biggest boost after the company said it will buy Future Group units to bolster its retail business.

Read: Future Group Bonds, Shares Soar After Ambani’s Purchase Plan

India’s two main equity indexes are closing in on record high levels touched in January after rebounding from a coronavirus-induced sell off in March even as the nation faces its worst ever quarterly contraction in gross domestic product due to disruptions caused by lockdowns. The economic scorecard is scheduled after markets close today.

Listen: Under the Hood of India’s Record Contraction: Podcast

Along with the economic malaise, coronavirus infections continue to soar, with the South Asian nation reaching a global record for daily cases. Still, almost two-thirds of Nifty 50 index-members that have reported quarterly earnings this season have posted results that met or exceeded analyst estimates. The three remaining companies yet to report have until Sept. 15 to file their statements.

The Numbers

  • All but one of 19 sectoral indexes compiled by BSE Ltd. fell, led by a gauge of healthcare stocks
  • ICICI Bank Ltd. contributed the most to the Sensex decline, decreasing 2.5% and reversing an earlier gain of 3%. Sun Pharmaceutical Industries Ltd. dropped the most, losing 3.9%

Market-related stories

  • India Faces Worst Quarterly GDP Slump Ever After Lockdown
  • India Becoming Virus Hotspot to Watch With Cases to Top Brazil

(Corrects to say the Sensex was on course to cap its longest run of monthly gains since December in the lead; also corrects the length of the streak to six months in 2016 in second paragraph)

©2020 Bloomberg L.P.

© Bloomberg. A digital ticker board is displayed at the Bombay Stock Exchange (BSE) building in Mumbai, India, on Monday, July 6, 2020. The Sensex is headed for a four-month high, even as India overtook Russia to become the country with the third-largest caseload of coronavirus infections. Only the U.S. and Brazil now have more infections than India. Photographer: Dhiraj Singh/Bloomberg

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.